How GLP-1 medications are transforming diabetes and weight loss treatment
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, Mounjaro and Zepbound.
Josh Gad Reveals How Much Weight He's Lost on GLP-1 Medication
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many celebrities have joined the ranks of those who swear by the medication, including Josh Gad,
Josh Gad Makes Bold Declaration About Weight Loss Drugs After Losing 40 Pounds
Josh Gad is the latest celebrity to talk about using a weight loss medication—and while his experience has been positive, he does have some doubts about his transformation. “I’m on a GLP-1...this is the first time I’ve opened up about this,
Josh Gad Has Lost 40 Lbs on GLP-1 Medication: 'It Is a Miracle Drug'
Josh Gad is opening up about the weight loss success he's had with GLP-1 medication - and sharing some of the conflicted feelings he's had along the way. "I'm on a GLP-1 … this is the first time I've opened up about this,
Josh Gad credits 'miracle drug' with helping him lose 40 pounds
During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication for weight loss. "I'm on a GLP-1... this is the first time I've opened up about this,
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Health and Me on MSN17h
GLP-1 Drugs Affect 175 Health Conditions, Benefits Heart But Pose Risk To Kidneys
A new study has examined the effects of GLP-1 drugs on 175 different health outcomes. ​​​While these drugs have been found to ...
GLP-1 Users Are Spending Way Less on Groceries and Fast Food, According to a New Study
Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
Medscape1d
GLP-1 for Complex Cases: Breakthrough Therapies That Transform Patient Care
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...
Endocrinology Advisor12h
GLP-1 Receptor Agonists May Have Broader Range of Benefits, Risks
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
GLP-1 drugs like Ozempic may have health benefits, but they come with risks
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
JD Supra4d
The GLP-1 Saga Continues: FDA Ends the Tirzepatide Shortage: Frequently Asked Questions
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
Rolling Out3d
Revolutionizing addiction treatment with GLP-1 agonists
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
Lexaria CEO says FY25 R&D will ‘remain concentrated’ on GLP-1 investigations
Lexaria Bioscience (LEXX) provided an annual letter from CEO Richard Christopher, which read in part, “In 2024, Lexaria made the course ...
Medscape8d
GLP-1 Benefits, Risks Detailed in ‘Atlas’ Mapping Outcomes
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...